Cerenome (PSTV) Current Deferred Revenue (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Current Deferred Revenue of $927000.0 for Q1 2026, down 28.53% year-over-year from $1.3 million in Q1 2025, and little changed quarter-over-quarter from $927000.0 in Q4 2025.
Cerenome (PSTV) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Current Deferred Revenue for 13 consecutive years, with $927000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 28.53% year-over-year to $927000.0; the TTM figure through Mar 2026 stood at $927000.0 (down 28.53% YoY), while the FY2025 annual figure was $927000.0, changed 0.0% from the prior year.
- Current Deferred Revenue held at $927000.0 in Q1 2026 per PSTV's latest filing, from $927000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $2.3 million in Q2 2024 and bottomed at $247000.0 in Q1 2024.
- Historically, Current Deferred Revenue has averaged $1.1 million across 4 years, with a median of $927000.0 in 2024.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue tumbled 78.28% — and 2025, when it jumped 425.1%.
- Plus Therapeutics' Current Deferred Revenue stood at $1.1 million in 2023, then dropped by 18.47% to $927000.0 in 2024, then changed by 0.0% to $927000.0 in 2025, then changed by 0.0% to $927000.0 in 2026.
- Business Quant data shows PSTV's Current Deferred Revenue at $927000.0 in Q1 2026, $927000.0 in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 927,000.00 |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 927,000.00 |
| Sep 30, 2024 | 840,000.00 |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 247,000.00 |
| Mar 31, 2023 | 1.14 Mn |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 178,000.00 |
| Dec 31, 2017 | 94,000.00 |
| Sep 30, 2017 | 103,000.00 |
| Jun 30, 2017 | 110,000.00 |
| Mar 31, 2017 | 109,000.00 |
| Dec 31, 2016 | 97,000.00 |
| Sep 30, 2016 | 97,000.00 |
| Jun 30, 2016 | 106,000.00 |
| Mar 31, 2016 | 101,000.00 |